Annovis Bio SG&A Expense (Quarterly) Trends

Annovis Bio Inc (ANVS)

6.65 -0.64 (-8.78%) USD | NYSE | May 28, 16:00

6.60 -0.05 (-0.75%) Pre-Market: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	1.295M
December 31, 2023	1.538M
September 30, 2023	1.026M
June 30, 2023	1.498M
March 31, 2023	2.184M
December 31, 2022	1.592M
September 30, 2022	2.361M
June 30, 2022	1.938M
March 31, 2022	3.104M
December 31, 2021	3.036M
September 30, 2021	1.473M
June 30, 2021	0.7096M
March 31, 2021	0.8396M

Date	Value
December 31, 2020	0.4975M
September 30, 2020	0.8849M
June 30, 2020	1.687M
March 31, 2020	0.5167M
December 31, 2019	0.1088M
September 30, 2019	0.2398M
June 30, 2019	0.30M
March 31, 2019	0.1808M
December 31, 2018	0.1548M
September 30, 2018	0.1245M
June 30, 2018	0.1909M
March 31, 2018	0.1322M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

0.1088M

Minimum

Dec 2019

3.104M

Maximum

Mar 2022

1.341M

Average

1.384M

Median

SG&A Expense (Quarterly) Benchmarks